These variations in CHI3L1 levels across studies highlight potential differences in the inflammatory responses between PD, AD, and other neurodegenerative diseases, underscoring the need for further research into CHI3L1’s role in PD. This evidence concerns the gene CHI3L1 and neurodegenerative disease.